XBiotech Inc.
XBITXBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Natrunix
Rheumatoid Arthritis
514G3 (2 mg/kg) plus standard IV antibiotic treatment
Staphylococcus Aureus Bacteremia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Natrunix | Phase 2 | Rheumatoid Arthritis | - | - |
514G3 (2 mg/kg) plus standard IV antibiotic treatment | Phase 2 | Staphylococcus Aureus Bacteremia | - | - |
Rheumatoid Arthritis
1 drug in this indication
Staphylococcus Aureus Bacteremia
1 drug in this indication
Pancreatic Cancer
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)